C3 inhibitors are used to treat paroxysmal nocturnal hemoglobinuria. They work by preventing destruction of red blood cells and immune cell activation.
C3 inhibitors are used to treat paroxysmal nocturnal hemoglobinuria (PNH) and geographic atrophy (GA) secondary to age-related macular degeneration. These medications work by inhibiting complement C3 proteins, which play a role in inflammation. C3 inhibitors are available as under-the-skin and into-the-eye injections. One example is pegcetacoplan (Empaveli, Syfovre).
PEGCETACOPLAN treats paroxysmal nocturnal hemoglobinuria (PNH), a condition that causes low levels of red blood cells (anemia) and blood clots. It works by slowing down an overactive immune system, which reduces the breakdown of red blood cells.
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.
Subscribe and save
Get prescription saving tips and more from GoodRx Health. Enter your email to sign up